Decreased transforming growth factor beta1 in autism: A potential link between immune dysregulation and impairment in clinical behavioral outcomes

Autism spectrum disorders (ASD) are characterized by impairment in social interactions, communication deficits, and restricted repetitive interests and behaviors. There is evidence of both immune dysregulation and autoimmune phenomena in autism. We examined the regulatory cytokine transforming growth factor beta-1 (TGF beta 1) because of its role in controlling immune responses. Plasma levels of active TGF beta 1 were evaluated in 75 children with ASD compared with 68 controls. Children with ASD had significantly lower plasma TGF beta 1 levels compared with typically developing controls (p=0.0017) and compared with children with developmental disabilities other than ASD (p=0.0037), after adjusting for age and gender. In addition, there were significant correlations between psychological measures and TGF beta 1 levels, such that lower TGF beta 1 levels were associated with lower adaptive behaviors and worse behavioral symptoms. The data suggest that immune responses in autism may be inappropriately regulated due to reductions in TGF beta 1. Such immune dysregulation may predispose to the development of possible autoimmune responses and/or adverse neuroimmune interactions during critical windows in development.

[1]  Irva Hertz-Picciotto,et al.  The CHARGE Study: An Epidemiologic Investigation of Genetic and Environmental Factors Contributing to Autism , 2006, Environmental health perspectives.

[2]  J. Bregman,et al.  Diagnosing Autism: Analyses of Data from the Autism Diagnostic Interview , 1997, Journal of autism and developmental disorders.

[3]  G. V. Kozlovskaia,et al.  [Nerve growth factor auto-antibodies in children with various forms of mental dysontogenesis and in schizophrenia high risk group]. , 2000, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[4]  Jareen Meinzen-Derr,et al.  Elevated cytokine levels in children with autism spectrum disorder , 2006, Journal of Neuroimmunology.

[5]  G. Dawson,et al.  Practice parameter: Screening and diagnosis of autism , 2000, Neurology.

[6]  S. Balk,et al.  References Subscriptions Permissions Email Alerts NK T Cell-Derived IL-10 Is Essential for the Differentiation of Antigen-Specific T Regulatory Cells in Systemic Tolerance , 2013 .

[7]  P. Ashwood,et al.  The immune response in autism: a new frontier for autism research , 2006, Journal of leukocyte biology.

[8]  M. Bevan,et al.  Cutting Edge: Lipopolysaccharide Induces IL-10-Producing Regulatory CD4+ T Cells That Suppress the CD8+ T Cell Response , 2007, The Journal of Immunology.

[9]  D. Amaral,et al.  Autoantibodies in Autism Spectrum Disorders (ASD) , 2007, Annals of the New York Academy of Sciences.

[10]  P. Ashwood,et al.  Spontaneous Mucosal Lymphocyte Cytokine Profiles in Children with Autism and Gastrointestinal Symptoms: Mucosal Immune Activation and Reduced Counter Regulatory Interleukin-10 , 2004, Journal of Clinical Immunology.

[11]  R. Flavell,et al.  Transforming growth factor (TGF-) and autoimmunity , 2005 .

[12]  M. Aman,et al.  The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. , 1985, American journal of mental deficiency.

[13]  H. Cohly,et al.  Immunological findings in autism. , 2005, International review of neurobiology.

[14]  V. Singh,et al.  Immunogenetic studies in autism and related disorders , 1996, Molecular and chemical neuropathology.

[15]  R. Flavell,et al.  Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. , 2006, Immunity.

[16]  Sudhir Gupta,et al.  Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism , 1998, Journal of Neuroimmunology.

[17]  U. Bogdahn,et al.  Transforming Growth Factor-&bgr;1 Is a Negative Modulator of Adult Neurogenesis , 2006, Journal of neuropathology and experimental neurology.

[18]  F. Gomes,et al.  Emerging roles for TGF-β1 in nervous system development , 2005, International Journal of Developmental Neuroscience.

[19]  Ruth A. Carper,et al.  Evidence of brain overgrowth in the first year of life in autism. , 2003, JAMA.

[20]  F. Gomes,et al.  Emerging roles for TGF-beta1 in nervous system development. , 2005, International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience.

[21]  C. Pingree,et al.  Increased frequency of the null allele at the complement C4b locus in autism , 1991, Clinical and experimental immunology.

[22]  Vijendra K. Singh,et al.  Abnormal Measles-Mumps-Rubella Antibodies and CNS Autoimmunity in Children with Autism , 2002, Journal of Biomedical Science.

[23]  V. Singh,et al.  Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism , 1996, Journal of Neuroimmunology.

[24]  A. Rudensky,et al.  Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. , 2006, Immunity.

[25]  V. Singh,et al.  Antibodies to Myelin Basic Protein in Children with Autistic Behavior , 1993, Brain, Behavior, and Immunity.

[26]  V. Singh,et al.  Circulating autoantibodies to neuronal and glial filament proteins in autism. , 1997, Pediatric neurology.

[27]  Ruth A. Carper,et al.  Unusual brain growth patterns in early life in patients with autistic disorder , 2001, Neurology.

[28]  S. Milstien,et al.  Cerebrospinal fluid and serum markers of inflammation in autism. , 2005, Pediatric neurology.

[29]  R. Neuman,et al.  Brain-Derived Neurotrophic Factor and Autoantibodies to Neural Antigens in Sera of Children with Autistic Spectrum Disorders, Landau-Kleffner Syndrome, and Epilepsy , 2006, Biological Psychiatry.

[30]  G. Proetzel,et al.  Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.

[31]  F. Guerini,et al.  Significant association of HLA A2-DR11 with CD4 naive decrease in autistic children. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[32]  A. Pestronk,et al.  Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. , 1999, The Journal of pediatrics.

[33]  E. Bosmans,et al.  Activation of the Inflammatory Response System in Autism , 2002, Neuropsychobiology.

[34]  A. Roberts,et al.  Regulation of immune responses by TGF-beta. , 1998, Annual review of immunology.

[35]  A. Zimmerman,et al.  Neuroglial activation and neuroinflammation in the brain of patients with autism , 2005, Annals of neurology.

[36]  James Lani,et al.  Mullen Scales of Early Learning (MSEL) , 2010 .

[37]  Károly Mirnics,et al.  Immune transcriptome alterations in the temporal cortex of subjects with autism , 2008, Neurobiology of Disease.

[38]  D. Cohen,et al.  Antibrain antibodies in infantile autism , 1988, Biological Psychiatry.

[39]  Ming Li,et al.  Transforming growth factor beta (TGF-beta) and autoimmunity. , 2005, Autoimmunity reviews.

[40]  J. Penninger,et al.  IL-10 Induces Regulatory T Cell Apoptosis by Up-Regulation of the Membrane Form of TNF-α 1 , 2004, The Journal of Immunology.

[41]  R. Flavell,et al.  Transforming Growth Factor-β Controls Development, Homeostasis, and Tolerance of T Cells by Regulatory T Cell-Dependent and -Independent Mechanisms , 2006 .

[42]  P. Ashwood,et al.  Brain‐Specific Autoantibodies in the Plasma of Subjects with Autistic Spectrum Disorder , 2007, Annals of the New York Academy of Sciences.

[43]  Wyatt H. Rivas,et al.  Prevalence of serum antibodies to caudate nucleus in autistic children , 2004, Neuroscience Letters.

[44]  岡田 京子.  Decreased serum levels of transforming growth factor-β1 in patients with autism , 2007 .

[45]  B. Leventhal,et al.  The Autism Diagnostic Observation Schedule—Generic: A Standard Measure of Social and Communication Deficits Associated with the Spectrum of Autism , 2000, Journal of autism and developmental disorders.

[46]  Anita B. Roberts,et al.  REGULATION OF IMMUNE RESPONSES BY TGF-β* , 1998 .

[47]  A. Torres,et al.  The association of MHC genes with autism. , 2001, Frontiers in bioscience : a journal and virtual library.

[48]  Vijendra K. Singh,et al.  Hyperserotoninemia and serotonin receptor antibodies in children with autism but not mental retardation , 1997, Biological Psychiatry.

[49]  Kozlovskaia Gv,et al.  [Nerve growth factor auto-antibodies in children with various forms of mental dysontogenesis and in schizophrenia high risk group]. , 2000 .

[50]  H. Jyonouchi,et al.  Dysregulated Innate Immune Responses in Young Children with Autism Spectrum Disorders: Their Relationship to Gastrointestinal Symptoms and Dietary Intervention , 2005, Neuropsychobiology.

[51]  P. Ashwood,et al.  Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms , 2006, Journal of Neuroimmunology.

[52]  Richard A Flavell,et al.  Transforming growth factor-beta regulation of immune responses. , 2006, Annual review of immunology.